Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Vertex Pharmaceuticals logo By Midea
Are Wall Street Analysts Bullish on Vertex Stock? Barchart - Thu Aug 20, 2:18AM CDT

Vertex Pharmaceuticals has raced ahead of the market, while analysts continue to give the stock a decidedly optimistic outlook.

XLV : 174.62 (+1.29%)
$SPX : 7,674.37 (+0.43%)
VRTX : 548.05 (+1.44%)
KRT
3 Cash-Producing Stocks on Our Watchlist StockStory - Mon Aug 17, 11:37PM CDT

3 Cash-Producing Stocks on Our Watchlist

VRTX : 548.05 (+1.44%)
KRT : 48.05 (+1.01%)
YOU : 43.29 (+0.91%)
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX Business Wire - Mon Aug 17, 11:57AM CDT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Crinetics Pharmaceuticals...

CRNX : 84.69 (unch)
VRTX : 548.05 (+1.44%)
VRTX
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call StockStory - Mon Aug 10, 12:31AM CDT

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

VRTX : 548.05 (+1.44%)
VRTX
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations StockStory - Mon Aug 3, 3:36PM CDT

Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations

VRTX : 548.05 (+1.44%)
Vertex: Q2 Earnings Snapshot AP - Mon Aug 3, 3:11PM CDT

Vertex: Q2 Earnings Snapshot

VRTX : 548.05 (+1.44%)
Vertex Reports Second Quarter 2026 Financial Results Business Wire - Mon Aug 3, 3:01PM CDT

— Total revenue of $3.33 billion, a 12% increase compared to second quarter 2025 — — Raising full-year revenue guidance to $13.1 billion to $13.2 billion — ...

VRTX : 548.05 (+1.44%)
Jobs Numbers Set for Release Next Week Baystreet - Sun Aug 2, 8:56PM CDT

Monday U.S. Economic Lookahead S&P final U.S. manufacturing PMI (July) ISM manufacturing ...

SONY : 23.92 (+1.44%)
SNDK : 1,596.08 (-0.28%)
COP : 134.87 (-0.01%)
NVO : 46.74 (+1.30%)
CAT : 827.90 (+1.53%)
MRK : 152.55 (+2.39%)
VRTX : 548.05 (+1.44%)
AMD : 473.25 (+0.81%)
LLY : 1,255.40 (+0.88%)
PH : 1,001.74 (+0.16%)
PLTR : 179.94 (+3.44%)
MAR : 356.39 (-0.06%)
VRTX
Vertex Pharmaceuticals (VRTX) Q2 Earnings Report Preview: What To Look For StockStory - Sat Aug 1, 10:05PM CDT

Vertex Pharmaceuticals (VRTX) Q2 Earnings Report Preview: What To Look For

VRTX : 548.05 (+1.44%)
Vertex: The Cystic Fibrosis Franchise Meets Its First Real Comps Test Barchart - Fri Jul 31, 4:10PM CDT

Barchart Research What to Expect from VRTX Earnings VRTX Generated July 31, 2026 Current Price $477.10 EPS Estimate $$4.30 Consensus Rating Moderate Buy Average Move 6.21% Vertex: The Cystic Fibrosis Franchise...

VRTX : 548.05 (+1.44%)

Barchart Exclusives

Rocket Lab and AST SpaceMobile Are Priced for the Big Bang. One Space Stock Already Delivered. Barchart - Fri Aug 21, 6:00PM CDT
Two space stocks are priced for a perfect future. A third is already cashing checks. Here's what Rocket Lab, AST SpaceMobile, and Karman really cost. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.